Moneyline: ResMed, Liberator Medical, Aeroflow
By HME News Staff
Updated Tue June 3, 2014
ResMed Director Christopher Roberts has sold 25,000 shares of the company's stock in a transaction that occurred May 29. The stock was sold at an average price of $49.73 for a total value of about $1.2 million. Roberts now owns 101,988 shares in the company for a total value of about $5 million. Earlier in May, Peter Farrell, the former CEO of ResMed and a current director, sold 25,000 shares at $49.80 for a total value of about $1.24 million, and Brett Sandercock, CFO, sold 4,290 shares at $50 for a value of about $214,500…The board of directors at Liberator Medical Holdings approved on May 30 a cash dividend of $0.03 per common share to its shareholders. This is the sixth quarterly cash dividend to be paid by the company. It will be paid on July 10, 2014, to all shareholders of record as of the close of business on June 26, 2014. Liberator began trading on the New York Stock Exchange in November…Aeroflow Healthcare has seen 14% growth since January, the company announced in a May 29 press release. Buoying that growth: In January, the company acquired Air-Care Home Health in South Carolina. Aeroflow's strategy includes buying existing HME companies and to leverage the contracts it won as part of Medicare's competitive bidding program. “Our goal is to bring Aeroflow's unprecedented care and low costs to existing companies, while continually growing our patient base,” said Josh Hill, director of business development, in the release.
Comments